Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000675463 | SCV000971583 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001538072 | SCV001755086 | benign | Neuronal ceroid lipofuscinosis 2 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001538073 | SCV001755087 | benign | Autosomal recessive spinocerebellar ataxia 7 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594090 | SCV005087357 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 83% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 77. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000675463 | SCV005322113 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675463 | SCV000801150 | benign | not provided | 2015-10-22 | no assertion criteria provided | clinical testing |